share_log

10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference

10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference

10x Genomics 將在第 44 屆年度道明考恩醫療保健會議上發表演講
PR Newswire ·  02/20 16:05

PLEASANTON, Calif., Feb. 20, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference on Tuesday, March 5, at 2:50 p.m. Eastern Time.

加利福尼亞州普萊森頓,2024年2月20日 /PRNewswire/ — 單細胞和空間生物學領域的領導者10x Genomics, Inc.(納斯達克股票代碼:TXG)今天宣佈,其管理團隊成員將參加44號的爐邊談話第四 年度TD Cowen醫療保健會議將於美國東部時間3月5日星期二下午 2:50 舉行。

Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: The webcast will be archived and available for replay for at least 45 days after the event.

有興趣的人士可以在公司網站的 “投資者” 欄目上觀看爐邊談話的網絡直播,網址爲:該網絡直播將在活動結束後至少45天內存檔並可供重播。

About 10x Genomics

大約 10 倍基因組學

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).

10x Genomics是一家生命科學技術公司,其產品旨在加速對生物學的掌握並促進人類健康。我們的綜合解決方案包括用於單細胞和空間生物學的儀器、耗材和軟件,可幫助學術和轉化研究人員以及生物製藥公司以與生物學複雜性相匹配的分辨率和規模了解生物系統。我們的產品是腫瘤學、免疫學、神經科學等領域取得突破的推動力,推動了改變世界對健康和疾病的理解的強大發現。要了解更多信息,請訪問 10xgenomics.com 或通過 LinkedIn 或 X(Twitter)聯繫我們。

Disclosure Information

披露信息

10x Genomics uses filings with the Securities and Exchange Commission, our website (), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.

10x Genomics使用向美國證券交易委員會提交的文件、我們的網站 ()、新聞稿、公開電話會議、公開網絡直播和我們的社交媒體賬戶作爲披露重大非公開信息的手段,並用於履行我們在FD法規下的披露義務。

Contacts

聯繫人

Investors: [email protected]

投資者: [電子郵件保護]

Media: [email protected]

媒體: [電子郵件保護]

SOURCE 10x Genomics, Inc

來源 10x Genomics, Inc

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論